Inogen (INGN) closed at $7.08 on October 26, 2026, down 0.3% from the previous close, on volume of 187,547 shares (30-day average 354,586).
Data as of October 26, 2026.
No headlines found.
Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026
Business Wire (Thu, 15-Oct 1:00 PM ET)
Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech
Business Wire (Wed, 30-Sep 4:05 PM ET)
Inogen Announces Second Quarter 2026 Financial Results
Business Wire (Thu, 6-Aug 4:05 PM ET)
Globe Newswire (Mon, 3-Aug 4:20 PM ET)
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
Inogen trades on the NASDAQ stock market under the symbol INGN.
As of October 27, 2026, INGN stock price was flat at $7.08 with 3,662 million shares trading.
INGN has a beta of 0.38, meaning it tends to be less sensitive to market movements. INGN has a correlation of 0.01 to the broad based SPY ETF.
INGN has a market cap of $187.89 million. This is considered a Micro Cap stock.
Last quarter Inogen reported $95 million in Revenue and $.00 earnings per share. This fell short of revenue expectation by $-36,000 and exceeded earnings estimates by $.08.
In the last 3 years, INGN traded as high as $13.33 and as low as $4.13.
The top ETF exchange traded funds that INGN belongs to (by Net Assets): IWM, VTI, IWN, VXF, DFAS.
INGN has underperformed the market in the last year with a return of -19.3%, while SPY returned +14.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in INGN shares. However, INGN has outperformed the market in the last 3 month and 2 week periods, returning +15.1% and +10.3%, while SPY returned +3.9% and -1.6%, respectively. This indicates INGN has been having a stronger performance recently.
INGN support price is $6.86 and resistance is $7.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INGN shares will trade within this expected range on the day.